WEBVTT

00:00:03.600 --> 00:00:10.560
Meet Kate, an induced pluripotent stem cell, or iPSC therapy researcher and developer.

00:00:10.560 --> 00:00:13.280
She  is focused on developing a differentiation

00:00:13.280 --> 00:00:18.160
protocol for a therapeutic iPSC-derived cell and

00:00:18.160 --> 00:00:22.920
on defining critical quality attributes, or CQAs.

00:00:22.920 --> 00:00:25.720
However, Kate’s iPSC research may run into

00:00:25.720 --> 00:00:29.360
delays with time-to-market, and she may face difficulties

00:00:29.360 --> 00:00:32.520
translating characterization to insights. 

00:00:32.520 --> 00:00:34.840
This is often due to low throughput, 

00:00:34.840 --> 00:00:38.120
and a lack of cell characterization insights. 

00:00:38.120 --> 00:00:41.200
Thankfully, Sartorius PSC Functional and

00:00:41.200 --> 00:00:45.440
Phenotypic Characterization Solution helps Kate’s R&D group

00:00:45.440 --> 00:00:49.520
deliver the CQAs that their Process Development group needs. 

00:00:49.520 --> 00:00:51.280
Let’s learn more!

00:00:52.000 --> 00:00:56.640
The Solution aids Kate and her team by controlling variability. 

00:00:57.360 --> 00:01:00.560
It ensures reproducibility of Kate’s experiments with

00:01:00.560 --> 00:01:04.720
consistent, xeno-free, serum-free growth medium,

00:01:04.720 --> 00:01:08.040
high-recovery cryopreservation medium,

00:01:08.040 --> 00:01:10.160
precise pipetting tools,

00:01:10.160 --> 00:01:13.040
and contamination checks.

00:01:13.040 --> 00:01:17.840
The Solution enables automation and throughput when developing protocols and

00:01:17.840 --> 00:01:22.640
performing phenotypic and functional characterization of iPSCs. 

00:01:22.640 --> 00:01:29.200
It enables the analysis of cells in 96 and 384 well plates and systematic

00:01:29.200 --> 00:01:35.440
validation of findings with 24-48 sample miniaturized assay platform.

00:01:35.440 --> 00:01:40.480
At the same time, Kate obtains a comprehensive understanding of iPSCs

00:01:40.480 --> 00:01:43.440
throughout the differentiation protocol thanks to

00:01:43.440 --> 00:01:48.040
continuous live-cell analysis and multiplex phenotyping.

00:01:48.040 --> 00:01:49.960
With the Sartorius Solution, 

00:01:49.960 --> 00:01:53.920
Kate is equipped with the information she needs in order to develop and 

00:01:53.920 --> 00:01:58.960
optimize differentiation protocols for her iPSC derivative and

00:01:58.960 --> 00:02:03.240
to identify the CQAs to enable process development.